Provexis plc (AIM:PXS)

Revenue by Segment

Financials in millions GBP. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Vitamins & Nutrition Products	1.29M	801.96K	389.92K	426.17K	505.33K
Vitamins & Nutrition Products Growth	61.13%	105.68%	-8.51%	-15.67%	45.24%
Total	1.29M	801.96K	389.92K	426.17K	505.33K
Total Growth	61.13%	105.68%	-8.51%	-15.67%	45.24%

Revenue by Geography

Financials in millions GBP. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
United Kingdom	1.29M	801.96K	389.92K	426.17K	505.33K
United Kingdom Growth	61.13%	105.68%	-8.51%	-15.67%	45.24%
Total	1.29M	801.96K	389.92K	426.17K	505.33K
Total Growth	61.13%	105.68%	-8.51%	-15.67%	45.24%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 15, 2026

Data Sources Report a data error